Rhythm Pharmaceuticals Inc (RYTM)
EBITDA Growth
-9.89%
Quarterly · Period ending:
RYTM EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-9.89%period ending
Latest reported-9.89%period ending
RYTM Quarterly EBITDA YoY % (-105683.33% → -9.89%)
Year-over-year change
High-resolution chart · PNG
RYTM ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -9.8855% | |
| -15.2042% | |
| -13.5732% | |
| -24.4773% | |
| -49.6846% | |
| 67.9013% | |
| -2.9668% | |
| 4.5916% | |
| 37.6391% | |
| -179.3038% | |
| 6.583% | |
| -5.0398% | |
| 3.502% | |
| 7.1603% | |
| 22.739% | |
| 12.5882% | |
| -11.0316% | |
| -53.2708% | |
| -44.8058% | |
| -28.3625% | |
| -26.3002% | |
| 2.6642% | |
| -2.5328% | |
| 7.5956% | |
| 27.757% | |
| -16.0462% | |
| -26.3429% | |
| -92.8937% | |
| -193.7299% | |
| -78.719% | |
| -146.6081% | |
| -132.5112% | |
| -123.2836% | |
| -167.4033% | |
| -31.2861% | |
| -29.7242% | |
| -17.4408% | |
| -105,683.3333% |